103 related articles for article (PubMed ID: 27884512)
1. Design, synthesis and antithrombotic evaluation of novel non-peptide thrombin inhibitors.
Chen D; Shi J; Liu J; Zhang X; Deng X; Yang Y; Cui S; Zhu Q; Gong G; Xu Y
Bioorg Med Chem; 2017 Jan; 25(2):458-470. PubMed ID: 27884512
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate.
Yang XZ; Diao XJ; Yang WH; Li F; He GW; Gong GQ; Xu YG
Bioorg Med Chem Lett; 2013 Apr; 23(7):2089-92. PubMed ID: 23466230
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors.
Wang S; Dai P; Xu Y; Chen Q; Zhu Q; Gong G
Arch Pharm (Weinheim); 2015 Aug; 348(8):595-605. PubMed ID: 26120827
[TBL] [Abstract][Full Text] [Related]
4. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity.
Yang XZ; Yang WH; Xu YG; Diao XJ; He GW; Gong GQ
Eur J Med Chem; 2012 Nov; 57():21-8. PubMed ID: 23043765
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models.
Peternel L; Stegnar M; Drevensek G; Budihna MV; Bozic M; Zega A; Stalc A; Cerne M; Urleb U
Thromb Haemost; 2005 Mar; 93(3):437-42. PubMed ID: 15735792
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antithrombotic evaluation of novel dabigatran etexilate analogs, a new series of non-peptides thrombin inhibitors.
Chen D; Wang S; Diao X; Zhu Q; Shen H; Han X; Wang Y; Gong G; Xu Y
Bioorg Med Chem; 2015 Dec; 23(23):7405-16. PubMed ID: 26537784
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Pehrsson S; Johansson K; Kjaer M; Elg M
Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors.
Li ML; Ren YJ; Dong MH; Ren WX
Eur J Med Chem; 2015; 96():122-38. PubMed ID: 25874337
[TBL] [Abstract][Full Text] [Related]
10. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
[TBL] [Abstract][Full Text] [Related]
11. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
[TBL] [Abstract][Full Text] [Related]
13. The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
Cho JH; Yun CH; Seo HS; Koga T; Dan T; Koo BA; Kim HY
Thromb Haemost; 2001 Dec; 86(6):1512-20. PubMed ID: 11776321
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin and heparin cofactor II-mediated inactivation of alpha-thrombin by a synthetic, sulfated mannogalactan.
Gracher AH; Cipriani TR; Carbonero ER; Gorin PA; Iacomini M
Thromb Res; 2010 Sep; 126(3):e180-7. PubMed ID: 20553946
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor.
Mendes-Silva W; Assafim M; Ruta B; Monteiro RQ; Guimarães JA; Zingali RB
Thromb Res; 2003; 112(1-2):93-8. PubMed ID: 15013279
[TBL] [Abstract][Full Text] [Related]
16. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
Song Q; Wang S; Zhao W
J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
Farias WR; Nazareth RA; Mourão PA
Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
[TBL] [Abstract][Full Text] [Related]
18. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
Elg M; Gustafsson D; Deinum J
Thromb Haemost; 1997 Oct; 78(4):1286-92. PubMed ID: 9364999
[TBL] [Abstract][Full Text] [Related]
19. Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.
Lu T; Markotan T; Ballentine SK; Giardino EC; Spurlino J; Crysler CS; Brown K; Maryanoff BE; Tomczuk BE; Damiano BP; Shukla U; End D; Andrade-Gordon P; Bone RF; Player MR
J Med Chem; 2010 Feb; 53(4):1843-56. PubMed ID: 20102150
[TBL] [Abstract][Full Text] [Related]
20. 5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor.
Meneyrol J; Follmann M; Lassalle G; Wehner V; Barre G; Rousseaux T; Altenburger JM; Petit F; Bocskei Z; Schreuder H; Alet N; Herault JP; Millet L; Dol F; Florian P; Schaeffer P; Sadoun F; Klieber S; Briot C; Bono F; Herbert JM
J Med Chem; 2013 Dec; 56(23):9441-56. PubMed ID: 24175584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
